Side Effects of Perioperative Intravesical Treatment and Treatment Strategies for These Side Effects
Urologic Clinics of North America, ISSN: 0094-0143, Vol: 40, Issue: 2, Page: 197-210
2013
- 23Citations
- 29Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations23
- Citation Indexes21
- 21
- CrossRef13
- Policy Citations2
- 2
- Captures29
- Readers29
- 29
Review Description
Perioperative intravesical chemotherapy has a well-established role in the treatment of non-muscle invasive bladder cancer. There are multiple agents that can be used in this fashion with varying properties. Although chemical cystitis is the most common side effect and is usually self-limiting, significant toxicity can occur with intravesical chemotherapy. It is imperative that the urologist is aware of the acute and delayed side effects of intravesical chemotherapy and how to manage potential complications. Both local and systemic toxicities are discussed, as well as strategies to minimize and manage them. © 2013 Elsevier Inc.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0094014313000062; http://dx.doi.org/10.1016/j.ucl.2013.01.005; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84876738346&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/23540778; https://linkinghub.elsevier.com/retrieve/pii/S0094014313000062; https://dx.doi.org/10.1016/j.ucl.2013.01.005
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know